Stock listing

Elicio Therapeutics, Inc.

Selected listing: A3CY4J · LS · EUR · DE

Elicio Therapeutics, Inc. (Lang & Schwarz: A3CY4J), Health Technology. Latest release Sep 24, 2026: Elicio Therapeutics Announces Late-Breaking Phase 2…

A3CY4J:LSEURDEUpdated October 2, 2026

Ticker: Lang & Schwarz: A3CY4J
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: Lang & Schwarz
Currency: EUR

Latest news from Elicio Therapeutics, Inc.

Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026

September 24, 2026

Elicio Therapeutics to Participate at the H.C. Wainwright 28th Annual Global Investment Conference

August 31, 2026

Elicio Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

August 24, 2026

Elicio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

August 13, 2026

Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma

August 10, 2026

All Elicio Therapeutics, Inc. news →

Research Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc. company profile

View the public company page for Elicio Therapeutics, Inc. on 6ix.

Elicio Therapeutics, Inc. news

Read company news and market updates connected to Elicio Therapeutics, Inc..

Elicio Therapeutics, Inc. investor events

Find investor webinars, events, and replay context for Elicio Therapeutics, Inc..